Topic
pharmaceutical-policy
2 stories related to this topic, newest first.
business15 days ago
Senators Advance Bill to Cap Insulin at $35 for Private Insurance and Uninsured
U.S. senators are reviving a proposal to extend the $35 insulin price cap beyond Medicare to the private market and uninsured patients. The measure is modeled on a 2022 law that already limits costs for Medicare beneficiaries.
Washington Examinerpolitics49 days ago
Trump Administration Considers Most Favored Nation Drug Pricing Policy
The proposal would link U.S. prescription drug prices to the lowest prices paid by foreign governments. A patient advocate argues the approach could reduce funding for pharmaceutical research and limit patient access to new medicines.